Plasminogen activator inhibitor type 2: still an enigmatic serpin but a model for gene regulation

Research output: Chapter in Book/Report/Conference proceedingChapter (Book)Researchpeer-review

Abstract

Plasminogen activator inhibitor type-2 (PAI-2; SERPINB2) is an atypical member of the Ov-serpin family of serine protease inhibitors. While it is an undisputed inhibitor of urokinase and tissue-type plasminogen activator in the extracellular space and on the cell surface, the weight of circumstantial evidence suggests that PAI-2 also fulfills an intracellular role which is independent of plasminogen activator inhibition and indeed may not even involve protease inhibition at all. More and more data continue to implicate a role for PAI-2 in many settings, the most recent associating it as a modulator of the innate immune response. Further to the debates concerning its physiological role, there are few genes, if any, that display the regulation profile of the PAI-2 gene: PAI-2 protein and mRNA levels can be induced in the order of, not hundred-, but thousand-folds in a process that is controlled at many levels including gene transcription and mRNA stability while an epigenetic component is also likely. The ability of some cells, including monocytes, fibroblasts, and neurons to have the capacity to increase PAI-2 synthesis to such high levels is intriguing enough. So why do these cells have the capacity to synthesize so much of this protein? While tantalizing clues continue to be revealed to the field, an understanding of how this gene is regulated so profoundly has provided insights into the broader mechanics of gene expression and regulation.
Original languageEnglish
Title of host publicationMethods in Enzymology, Volume 499: Biology of Serpins
EditorsJames C Whisstock, Phillip I Bird
Place of PublicationUSA
PublisherAcademic Press
Pages105 - 134
Number of pages30
ISBN (Print)9780123864710
DOIs
Publication statusPublished - 2011

Cite this

Medcalf, R. (2011). Plasminogen activator inhibitor type 2: still an enigmatic serpin but a model for gene regulation. In J. C. Whisstock, & P. I. Bird (Eds.), Methods in Enzymology, Volume 499: Biology of Serpins (pp. 105 - 134). USA: Academic Press. https://doi.org/10.1016/B978-0-12-386471-0.00006-7
Medcalf, Robert. / Plasminogen activator inhibitor type 2: still an enigmatic serpin but a model for gene regulation. Methods in Enzymology, Volume 499: Biology of Serpins. editor / James C Whisstock ; Phillip I Bird. USA : Academic Press, 2011. pp. 105 - 134
@inbook{cbbf03246a184d52b51f095bc5c24e6a,
title = "Plasminogen activator inhibitor type 2: still an enigmatic serpin but a model for gene regulation",
abstract = "Plasminogen activator inhibitor type-2 (PAI-2; SERPINB2) is an atypical member of the Ov-serpin family of serine protease inhibitors. While it is an undisputed inhibitor of urokinase and tissue-type plasminogen activator in the extracellular space and on the cell surface, the weight of circumstantial evidence suggests that PAI-2 also fulfills an intracellular role which is independent of plasminogen activator inhibition and indeed may not even involve protease inhibition at all. More and more data continue to implicate a role for PAI-2 in many settings, the most recent associating it as a modulator of the innate immune response. Further to the debates concerning its physiological role, there are few genes, if any, that display the regulation profile of the PAI-2 gene: PAI-2 protein and mRNA levels can be induced in the order of, not hundred-, but thousand-folds in a process that is controlled at many levels including gene transcription and mRNA stability while an epigenetic component is also likely. The ability of some cells, including monocytes, fibroblasts, and neurons to have the capacity to increase PAI-2 synthesis to such high levels is intriguing enough. So why do these cells have the capacity to synthesize so much of this protein? While tantalizing clues continue to be revealed to the field, an understanding of how this gene is regulated so profoundly has provided insights into the broader mechanics of gene expression and regulation.",
author = "Robert Medcalf",
year = "2011",
doi = "10.1016/B978-0-12-386471-0.00006-7",
language = "English",
isbn = "9780123864710",
pages = "105 -- 134",
editor = "Whisstock, {James C} and Bird, {Phillip I}",
booktitle = "Methods in Enzymology, Volume 499: Biology of Serpins",
publisher = "Academic Press",
address = "United States of America",

}

Medcalf, R 2011, Plasminogen activator inhibitor type 2: still an enigmatic serpin but a model for gene regulation. in JC Whisstock & PI Bird (eds), Methods in Enzymology, Volume 499: Biology of Serpins. Academic Press, USA, pp. 105 - 134. https://doi.org/10.1016/B978-0-12-386471-0.00006-7

Plasminogen activator inhibitor type 2: still an enigmatic serpin but a model for gene regulation. / Medcalf, Robert.

Methods in Enzymology, Volume 499: Biology of Serpins. ed. / James C Whisstock; Phillip I Bird. USA : Academic Press, 2011. p. 105 - 134.

Research output: Chapter in Book/Report/Conference proceedingChapter (Book)Researchpeer-review

TY - CHAP

T1 - Plasminogen activator inhibitor type 2: still an enigmatic serpin but a model for gene regulation

AU - Medcalf, Robert

PY - 2011

Y1 - 2011

N2 - Plasminogen activator inhibitor type-2 (PAI-2; SERPINB2) is an atypical member of the Ov-serpin family of serine protease inhibitors. While it is an undisputed inhibitor of urokinase and tissue-type plasminogen activator in the extracellular space and on the cell surface, the weight of circumstantial evidence suggests that PAI-2 also fulfills an intracellular role which is independent of plasminogen activator inhibition and indeed may not even involve protease inhibition at all. More and more data continue to implicate a role for PAI-2 in many settings, the most recent associating it as a modulator of the innate immune response. Further to the debates concerning its physiological role, there are few genes, if any, that display the regulation profile of the PAI-2 gene: PAI-2 protein and mRNA levels can be induced in the order of, not hundred-, but thousand-folds in a process that is controlled at many levels including gene transcription and mRNA stability while an epigenetic component is also likely. The ability of some cells, including monocytes, fibroblasts, and neurons to have the capacity to increase PAI-2 synthesis to such high levels is intriguing enough. So why do these cells have the capacity to synthesize so much of this protein? While tantalizing clues continue to be revealed to the field, an understanding of how this gene is regulated so profoundly has provided insights into the broader mechanics of gene expression and regulation.

AB - Plasminogen activator inhibitor type-2 (PAI-2; SERPINB2) is an atypical member of the Ov-serpin family of serine protease inhibitors. While it is an undisputed inhibitor of urokinase and tissue-type plasminogen activator in the extracellular space and on the cell surface, the weight of circumstantial evidence suggests that PAI-2 also fulfills an intracellular role which is independent of plasminogen activator inhibition and indeed may not even involve protease inhibition at all. More and more data continue to implicate a role for PAI-2 in many settings, the most recent associating it as a modulator of the innate immune response. Further to the debates concerning its physiological role, there are few genes, if any, that display the regulation profile of the PAI-2 gene: PAI-2 protein and mRNA levels can be induced in the order of, not hundred-, but thousand-folds in a process that is controlled at many levels including gene transcription and mRNA stability while an epigenetic component is also likely. The ability of some cells, including monocytes, fibroblasts, and neurons to have the capacity to increase PAI-2 synthesis to such high levels is intriguing enough. So why do these cells have the capacity to synthesize so much of this protein? While tantalizing clues continue to be revealed to the field, an understanding of how this gene is regulated so profoundly has provided insights into the broader mechanics of gene expression and regulation.

UR - http://pdn.sciencedirect.com/science?_ob=MiamiImageURL&_cid=273025&_user=542840&_pii=B9780123864710000067&_check=y&_origin=search&_zone=rslt_list_item

U2 - 10.1016/B978-0-12-386471-0.00006-7

DO - 10.1016/B978-0-12-386471-0.00006-7

M3 - Chapter (Book)

SN - 9780123864710

SP - 105

EP - 134

BT - Methods in Enzymology, Volume 499: Biology of Serpins

A2 - Whisstock, James C

A2 - Bird, Phillip I

PB - Academic Press

CY - USA

ER -

Medcalf R. Plasminogen activator inhibitor type 2: still an enigmatic serpin but a model for gene regulation. In Whisstock JC, Bird PI, editors, Methods in Enzymology, Volume 499: Biology of Serpins. USA: Academic Press. 2011. p. 105 - 134 https://doi.org/10.1016/B978-0-12-386471-0.00006-7